These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 26433482)
1. Astragaloside IV attenuates apoptosis of hypertrophic cardiomyocyte through inhibiting oxidative stress and calpain-1 activation. Mei M; Tang F; Lu M; He X; Wang H; Hou X; Hu J; Xu C; Han R Environ Toxicol Pharmacol; 2015 Nov; 40(3):764-73. PubMed ID: 26433482 [TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis. Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576 [TBL] [Abstract][Full Text] [Related]
3. Effect of astragaloside IV against rat myocardial cell apoptosis induced by oxidative stress via mitochondrial ATP-sensitive potassium channels. Guan FY; Yang SJ; Liu J; Yang SR Mol Med Rep; 2015 Jul; 12(1):371-6. PubMed ID: 25739067 [TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV improves the isoproterenol-induced vascular dysfunction via attenuating eNOS uncoupling-mediated oxidative stress and inhibiting ROS-NF-κB pathways. Xu C; Tang F; Lu M; Yang J; Han R; Mei M; Hu J; Zhou M; Wang H Int Immunopharmacol; 2016 Apr; 33():119-27. PubMed ID: 26903414 [TBL] [Abstract][Full Text] [Related]
5. Taurine attenuates isoproterenol-induced H9c2 cardiomyocytes hypertrophy by improving antioxidative ability and inhibiting calpain-1-mediated apoptosis. Li W; Yang J; Lyu Q; Wu G; Lin S; Yang Q; Hu J Mol Cell Biochem; 2020 Jun; 469(1-2):119-132. PubMed ID: 32304004 [TBL] [Abstract][Full Text] [Related]
7. Compatibility of Tanshinone IIA and Astragaloside IV in attenuating hypoxia-induced cardiomyocytes injury. Wang D; Liu Y; Zhong G; Wang Y; Zhang T; Zhao Z; Yan X; Liu Q J Ethnopharmacol; 2017 May; 204():67-76. PubMed ID: 28389356 [TBL] [Abstract][Full Text] [Related]
8. Platycodin D inhibits oxidative stress and apoptosis in H9c2 cardiomyocytes following hypoxia/reoxygenation injury. Wang Y; Che J; Zhao H; Tang J; Shi G Biochem Biophys Res Commun; 2018 Sep; 503(4):3219-3224. PubMed ID: 30146261 [TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4/NF-кB signaling pathway in isoproterenol-induced myocardial hypertrophy. Yang J; Wang HX; Zhang YJ; Yang YH; Lu ML; Zhang J; Li ST; Zhang SP; Li G J Ethnopharmacol; 2013 Dec; 150(3):1062-70. PubMed ID: 24432369 [TBL] [Abstract][Full Text] [Related]
10. Astragaloside IV Prevents Cardiac Remodeling in the Apolipoprotein E-Deficient Mice by Regulating Cardiac Homeostasis and Oxidative Stress. Li XZ; Ding YZ; Wu HF; Bian ZP; Xu JD; Gu CR; Chen XJ; Yang D Cell Physiol Biochem; 2017; 44(6):2422-2438. PubMed ID: 29268252 [TBL] [Abstract][Full Text] [Related]
11. Blueberry polyphenols prevent cardiomyocyte death by preventing calpain activation and oxidative stress. Louis XL; Thandapilly SJ; Kalt W; Vinqvist-Tymchuk M; Aloud BM; Raj P; Yu L; Le H; Netticadan T Food Funct; 2014 Aug; 5(8):1785-94. PubMed ID: 24910858 [TBL] [Abstract][Full Text] [Related]
12. Astragaloside IV protects against cardiac hypertrophy via inhibiting the Ca2+/CaN signaling pathway. Lu M; Wang H; Wang J; Zhang J; Yang J; Liang L; Maslov LN Planta Med; 2014 Jan; 80(1):63-9. PubMed ID: 24338553 [TBL] [Abstract][Full Text] [Related]
13. Astragaloside-IV Protects Against Heat-induced Apoptosis by Inhibiting Excessive Activation of Mitochondrial Ca2+ Uniporter. Dong Z; Zhang C; Chen Y; Chen Y; Yuan Z; Peng Y; Cao T Cell Physiol Biochem; 2017; 42(2):480-494. PubMed ID: 28578342 [TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV prevents kidney injury caused by iatrogenic hyperinsulinemia in a streptozotocin‑induced diabetic rat model. He KQ; Li WZ; Chai XQ; Yin YY; Jiang Y; Li WP Int J Mol Med; 2018 Feb; 41(2):1078-1088. PubMed ID: 29207011 [TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV attenuates myocardial ischemia/reperfusion injury in rats via inhibition of calcium-sensing receptor-mediated apoptotic signaling pathways. Yin B; Hou XW; Lu ML Acta Pharmacol Sin; 2019 May; 40(5):599-607. PubMed ID: 30030530 [TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV attenuates hypoxia-induced cardiomyocyte damage in rats by upregulating superoxide dismutase-1 levels. Hu JY; Han J; Chu ZG; Song HP; Zhang DX; Zhang Q; Huang YS Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):351-7. PubMed ID: 18986331 [TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV Exerts a Myocardial Protective Effect against Cardiac Hypertrophy in Rats, Partially via Activating the Nrf2/HO-1 Signaling Pathway. Nie P; Meng F; Zhang J; Wei X; Shen C Oxid Med Cell Longev; 2019; 2019():4625912. PubMed ID: 31285785 [TBL] [Abstract][Full Text] [Related]
18. Exogenous hydrogen sulfide prevents cardiomyocyte apoptosis from cardiac hypertrophy induced by isoproterenol. Lu F; Xing J; Zhang X; Dong S; Zhao Y; Wang L; Li H; Yang F; Xu C; Zhang W Mol Cell Biochem; 2013 Sep; 381(1-2):41-50. PubMed ID: 23660955 [TBL] [Abstract][Full Text] [Related]
19. [The effect of mitochondrial oxidative stress and the expression of Bcl-2 and Bax proteins on cardiomyocyte apoptosis during hypoxia postconditioning]. Tu RH; Chen L; Zhong GQ; Zeng ZY; Li QJ; He Y; He Y; Li JY Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jun; 40(6):516-21. PubMed ID: 22943649 [TBL] [Abstract][Full Text] [Related]